Limits of Fat Quantification in the Presence of Iron Overload.


Journal

Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850

Informations de publication

Date de publication:
10 2021
Historique:
revised: 09 03 2021
received: 30 11 2020
accepted: 10 03 2021
pubmed: 31 3 2021
medline: 30 9 2021
entrez: 30 3 2021
Statut: ppublish

Résumé

Chemical shift encoded magnetic resonance imaging (CSE-MRI)-based tissue fat quantification is confounded by increased R2* signal decay rate caused by the presence of excess iron deposition. To determine the upper limit of R2* above which it is no longer feasible to quantify proton density fat fraction (PDFF) reliably, using CSE-MRI. Prospective. Cramér-Rao lower bound (CRLB) calculations, Monte Carlo simulations, phantom experiments, and a prospective study in 26 patients with known or suspected liver iron overload. Multiecho gradient echo at 1.5 T and 3.0 T. CRLB calculations were used to develop an empirical relationship between the maximum R2* value above which PDFF estimation will achieve a desired number of effective signal averages. A single voxel multi-TR, multi-TE stimulated echo acquisition mode magnetic resonance spectroscopy acquisition was used as a reference standard to estimate PDFF. Reconstructed PDFF and R2* maps were analyzed by one analyst using multiple regions of interest drawn in all nine Couinaud segments. None. Simulations, phantom experiments, and in vivo measurements demonstrated unreliable PDFF estimates with increased R2*, with PDFF errors as large as 20% at an R2* of 1000 s We successfully developed a theoretically-based empirical formula that may provide an easily calculable guideline to identify R2* values above which PDFF is not reliable in research and clinical applications using CSE-MRI to quantify PDFF in the presence of iron overload. 1 TECHNICAL EFFICACY STAGE: 1.

Sections du résumé

BACKGROUND
Chemical shift encoded magnetic resonance imaging (CSE-MRI)-based tissue fat quantification is confounded by increased R2* signal decay rate caused by the presence of excess iron deposition.
PURPOSE
To determine the upper limit of R2* above which it is no longer feasible to quantify proton density fat fraction (PDFF) reliably, using CSE-MRI.
STUDY TYPE
Prospective.
POPULATION
Cramér-Rao lower bound (CRLB) calculations, Monte Carlo simulations, phantom experiments, and a prospective study in 26 patients with known or suspected liver iron overload.
FIELD STRENGTH/SEQUENCE
Multiecho gradient echo at 1.5 T and 3.0 T.
ASSESSMENT
CRLB calculations were used to develop an empirical relationship between the maximum R2* value above which PDFF estimation will achieve a desired number of effective signal averages. A single voxel multi-TR, multi-TE stimulated echo acquisition mode magnetic resonance spectroscopy acquisition was used as a reference standard to estimate PDFF. Reconstructed PDFF and R2* maps were analyzed by one analyst using multiple regions of interest drawn in all nine Couinaud segments.
STATISTICAL TESTS
None.
RESULTS
Simulations, phantom experiments, and in vivo measurements demonstrated unreliable PDFF estimates with increased R2*, with PDFF errors as large as 20% at an R2* of 1000 s
DATA CONCLUSION
We successfully developed a theoretically-based empirical formula that may provide an easily calculable guideline to identify R2* values above which PDFF is not reliable in research and clinical applications using CSE-MRI to quantify PDFF in the presence of iron overload.
LEVEL OF EVIDENCE
1 TECHNICAL EFFICACY STAGE: 1.

Identifiants

pubmed: 33783066
doi: 10.1002/jmri.27611
pmc: PMC8440489
mid: NIHMS1731357
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1166-1174

Subventions

Organisme : NIDDK NIH HHS
ID : K24 DK102595
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK117354
Pays : United States
Organisme : NIBIB NIH HHS
ID : R44 EB025729
Pays : United States
Organisme : NIBIB NIH HHS
ID : R41 EB025729
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK100651
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK088925
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021 International Society for Magnetic Resonance in Medicine.

Références

J Magn Reson Imaging. 2015 Sep;42(3):811-7
pubmed: 25620624
AJR Am J Roentgenol. 2017 Sep;209(3):592-603
pubmed: 28705058
Hepatology. 2002 Feb;35(2):373-9
pubmed: 11826411
World J Gastroenterol. 2016 Sep 28;22(36):8112-22
pubmed: 27688653
Magn Reson Med. 2012 Mar;67(3):638-44
pubmed: 21713978
Radiology. 2018 Feb;286(2):486-498
pubmed: 28892458
Can J Gastroenterol Hepatol. 2018 Jul 2;2018:2784537
pubmed: 30065915
Magn Reson Med. 2008 Nov;60(5):1122-34
pubmed: 18956464
Magn Reson Med. 2018 Aug;80(2):685-695
pubmed: 29322549
N Engl J Med. 1999 Dec 23;341(26):1986-95
pubmed: 10607817
N Engl J Med. 2012 Jan 26;366(4):348-59
pubmed: 22276824
Radiology. 2011 Mar;258(3):767-75
pubmed: 21248233
Radiology. 2011 Mar;258(3):749-59
pubmed: 21212366
Curr Gastroenterol Rep. 2012 Feb;14(1):8-16
pubmed: 22124850
Hepatology. 2010 Feb;51(2):679-89
pubmed: 20041406
Magn Reson Med. 2011 Jul;66(1):199-206
pubmed: 21695724
Radiology. 1996 Apr;199(1):13-22
pubmed: 8633135
Magn Reson Med. 2007 Aug;58(2):354-64
pubmed: 17654578
J Magn Reson Imaging. 2015 Dec;42(6):1538-43
pubmed: 26114603
Magn Reson Med. 2010 Jan;63(1):79-90
pubmed: 19859956
J Hepatol. 2011 Oct;55(4):920-32
pubmed: 21718726
J Magn Reson Imaging. 2009 Jun;29(6):1332-9
pubmed: 19472390
Magn Reson Med. 2010 Sep;64(3):811-22
pubmed: 20593375
Magn Reson Med. 2017 Aug;78(2):730-738
pubmed: 27650137
Magn Reson Med. 2005 Sep;54(3):625-35
pubmed: 16092102
Magn Reson Imaging. 2008 Apr;26(3):347-59
pubmed: 18093781
Dig Liver Dis. 2020 Jun;52(6):683-685
pubmed: 32359860
NMR Biomed. 2011 Aug;24(7):784-90
pubmed: 21834002
Radiology. 2009 Apr;251(1):67-76
pubmed: 19221054

Auteurs

Timothy J Colgan (TJ)

Department of Radiology, University of Wisconsin, Madison, Wisconsin, USA.

Ruiyang Zhao (R)

Department of Radiology, University of Wisconsin, Madison, Wisconsin, USA.
Department of Electrical and Computer Engineering, University of Wisconsin, Madison, Wisconsin, USA.

Nathan T Roberts (NT)

Department of Radiology, University of Wisconsin, Madison, Wisconsin, USA.
Department of Electrical and Computer Engineering, University of Wisconsin, Madison, Wisconsin, USA.

Diego Hernando (D)

Department of Radiology, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Physics, University of Wisconsin, Madison, Wisconsin, USA.

Scott B Reeder (SB)

Department of Radiology, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Physics, University of Wisconsin, Madison, Wisconsin, USA.
Department of Biomedical Engineering, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Department of Emergency Medicine, University of Wisconsin, Madison, Wisconsin, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH